Researchers at the University of Queensland (UQ) and EMvision Medical Devices in Australia have developed a portable, non-invasive brain scanner to obtain three-dimensional (3D) images of the brain.

Designed using technology licensed to EMvision by the university’s UniQuest firm, the new device uses an algorithm to map the brain tissue with safe, low-power microwaves for delivering 3D images.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The scanner is anticipated to accelerate diagnosis of brain injuries and stroke, as well as reduce brain damage and related rehabilitation costs.

EMvision Medical Devices CEO John Keep said: “In the case of stroke, the 3D image would enable medical professionals to quickly identify if damage is a haemorrhage or clot and to treat the patient accordingly, saving precious time.

“The difference between permanent disability or death and a positive recovery is timely diagnosis and treatment. Every hour appropriate treatment is delayed, the brain ages by about 3.6 years.”

EMvision is currently refining the prototype of the device to meet safety and efficacy requirements, as well as allow easy integration into clinical pathways.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
“The 3D image would enable medical professionals to quickly identify if damage is a haemorrhage or clot and to treat the patient accordingl.”

The firm intends to carry out a pilot clinical trial at the Princess Alexandra Hospital in the coming months.

Researchers expect that the device with life-saving potential will be useful in emergency departments, ambulances and remote locations.

UniQuest CEO Dr Dean Moss said: “The portability, cost-effectiveness and safety of this device is a very attractive proposition for the healthcare industry, with potential for use in both hospitals and ambulances throughout the world.

“It is also ideal for use in rural and remote areas. In Australia, rural and remote stroke patients are 20% more likely to die than their metropolitan counterparts due to delayed diagnosis.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact